Podcast:Scouting for Growth Published On: Thu Oct 05 2023 Description: On this episode of the Scouting For Growth podcast, Sabine VdL talks to Dr Andrée Bates, neuroscientist and founder of Eularis, an AI-centric company that serves as a catalyst for innovation in healthcare. The pair delves into the pivot points that drive innovation, the ethical implications of widespread AI adoption, and the tangible ways in which artificial intelligence is reshaping healthcare as we know it. KEY TAKEAWAYS Eularis was created to examine mathematics in commercial activities within the pharmaceutical industry. Generative AI takes elements of real data, looks at the database on which it’s been trained, makes new connections, and generates something new. We’re going to have to get to a point where we have some kind of digital certificate in our voice, our video, images, that authenticates whether it’s actually us or not, almost like a digital fingerprint BEST MOMENTS ‘AI is a broad term; there are so many different types of techniques which are classified as artificial intelligence, and under each one, there are different types.’ ‘We can use AI to repurpose existing drugs – and this happened with Covid.’ ‘I’ve recently come across AI that is predicting with very high accuracy whether a drug will be successful or not in the long term. That’s set to revolutionise the industry.’ ABOUT THE GUEST Dr Andrée Bates stands at the intersection of artificial intelligence, healthcare, and entrepreneurship. A seasoned neuroscientist and a disruptive tech innovator, she has trailblazed the healthcare industry since the early '90s. Dr Bates founded Eularis, a vanguard firm leveraging AI to address healthcare's most pressing challenges, back in 2003. Under her leadership, Eularis has catalysed growth for all the top 50 pharmaceutical giants, driving profits and expanding market share through AI-empowered projects in clinical trials, R&D, and medical affairs. After launching her career in academia, Dr. Bates made a seamless transition into the corporate sphere, where she continued her legacy of firsts. She is credited with establishing the world's first digital health company in the 1990s, followed by the pioneering of commercial AI applications in healthcare. This entrepreneurial spirit has positioned her as a go-to advisor for an impressive roster of healthcare CEOs. Her influence extends to both academia and industry circles. Dr. Bates is a sought-after guest lecturer in prestigious MBA programs, including INSEAD Business School and Fordham University, where she instills the next generation with a nuanced understanding of healthcare innovation and AI. A prolific author, her work has appeared in peer-reviewed journals and industry reports. Her international speaking engagements span continents, ranging from Europe and North America to Asia. Never one to limit her impact, Dr Bates actively champions female entrepreneurs worldwide. She serves as a mentor through Thrive Mentoring, contributes to the programming committee of the Healthcare Businesswomen's Association (HBA), and is a founding member of Chief, a network designed for women leaders. ABOUT THE HOST Sabine VanderLinden is a corporate strategist turned entrepreneur and the CEO of Alchemy Crew Ventures. She leads venture-client labs that help Fortune 500 companies adopt and scale cutting-edge technologies from global tech ventures. A builder of accelerators, investor, and co-editor of the bestseller The INSURTECH Book, Sabine is known for asking the uncomfortable questions—about AI governance, risk, and trust. On Scouting for Growth, she decodes how real growth happens—where capital, collaboration, and courage meet. If this episode sparked your thinking, follow Sabine VanderLinden on LinkedIn, Twitter, and Instagram for more insights. And if you’re interested in sponsoring the podcast, reach out to the team at hello@alchemycrew.ventures